Trial Profile
Population Pharmacokinetic (PK) Study of Zinforo (Ceftaroline) in Critical Care Patients With Early-onset Pneumonia and Normal or Augmented Renal Clearance
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Sep 2022
Price :
$35
*
At a glance
- Drugs Ceftaroline fosamil (Primary)
- Indications Gram-negative infections; Gram-positive infections; Methicillin-resistant Staphylococcus aureus infections; Pneumonia
- Focus Pharmacokinetics
- Acronyms CEFTAREA
- 05 Sep 2022 Results published in the Journal of Antimicrobial Chemotherapy
- 15 Feb 2019 Status changed from recruiting to completed.
- 15 Mar 2017 Status changed from not yet recruiting to recruiting.